Stay updated on Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.

Latest updates to the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous v3.2.0, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRemoved an ancillary notice about government funding and potential information updates, which does not affect the core study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedThe screenshots show the same study details page with cosmetic layout adjustments. There are no additions or deletions to core content such as eligibility criteria, locations, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedThe study results status changed from No Results Posted to Results Submitted, indicating that results have been submitted for posting.SummaryDifference0.0%

- Check62 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference5%

- Check69 days agoChange DetectedAdded revision label v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision note v3.0.2.SummaryDifference0.7%

Stay in the know with updates to Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.